Post by Elephas

In case you missed it, precision-cut tissue slices are explicitly named as qualifying New Approach Methodologies (NAMs) under the NIH's new funding framework! https://lnkd.in/eiMwezUf With human-relevant data, drug developers get earlier, more confident go/no-go decisions — before clinical trial investment. For labs considering how to align their study design with current NIH priorities, connect with our team to learn how elive™ could accelerate scientific discovery. Explore the platform here: https://lnkd.in/emTbf28R #Elephas #TransformingOncologyDiagnostics #Immunotherapy #Research #CancerOutcomes #Innovation #CancerResearch #Pharma #BioPharma #Healthcare #DrugDevelopment #BioTech